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Electroacupuncture (EA) therapy has been widely accepted as a useful therapeutic technique with low or no risk in the clinical
prevention of cardiac hypertrophy. However, the signaling transduction mechanism underlying this eﬀect remains unclear. The
current study investigates the eﬀects of EA on the signaling pathways of myocardial hypertrophy (MH) in rats. Up to 40 3-month-
old Sprague-Dawley (SD) rats were randomly divided into normal, model, PC6 (Neiguan), and LI4 (Hegu) groups, with ten rats
in each group. All the rats except for the normal group received 3mg/kg·d of isoprinosine hydrochloride (ISO) injection into
the back skin. The rats in the PC6 and LI4 groups received EA for 14 days. On the 15th day, electrocardiograms were recorded,
and the ultrastructure of the myocardial cells was observed. The myocardial hypertrophy indices (MHIs), electrocardiograph
(ECG), ultrastructure observation, levels of plasma angiotensin II (Ang II) and endothelin (ET), as well as protein expression
of extracellular signal-regulated kinase (ERK), and phosphorylation extracellular signal regulating kinase (p-ERK) in the left
ventricularmyocardialtissueweremeasured.TheresultsindicatedthatEAcanimprovecardiacfunctioninMHratsbymodulating
upstream neuroendocrine cytokines that regulate the ERK signaling pathways.
1.Introduction
In long-lasting pathologic emergency cases, myocardial
hypertrophy (MH) may lead to coronary heart disease,
congestive heart failure, stroke, and so on and can easily
cause patient death or sudden death [1]. On a cellular and
molecular level, the pathogenesis of MH may divide into
three links, namely, extracellular hypertrophic stimulation,
intracellular signal transduction, and intranuclear gene tran-
scriptional activation, and eventually trigger hypertrophic
myocardial cell changes. The intracellular signaling pathway
is the coupling link of exocellular stimulus and nuclear gene
activation. Thus, this signaling pathway has been proven as
a sally port for researching the pathogenesis of MH, with
extensive prospects for its application [2].
Angiotensin II (Ang II) and endothelin (ET) play a
central part in MH, myoﬁbrosis cordis, and cardiovascular
reconstruction process. Lines of evidence showed that Ang
II could enhance the expression of immediate early gene
IEG (c-fos, c-jun, c-myc, etc.), terminal myocardial cell
genes (skeleton actin, atrial natriuretic polypeptide), and
transforming growth factor β gene in rat myocardial cells,
conﬁrming that the upregulation of these genes induces
ventricularhypertrophyintheratmodel[3].Borgesetal.[4]
revealed that Ang II could facilitate MH and cardiovascular
reconstruction, depending mainly on local secretion and
release.ETispolypeptidethatcausesvasoconstriction,witha
slow, but long-lasting and wide eﬀect [5]. ET-1 causes strong
coronary arterial constriction and has positive chronotropic
action and positive inotropic action; therefore, it plays an
important part in myocardial infarction [6]. These two
neuroendocrine cytokines play an essential role in MH
and act as upstream factors of extracellular signal-regulated
kinase (ERK) signaling pathways [7].2 Evidence-Based Complementary and Alternative Medicine
ERK plays a key role in MH reaction, including gene
expression and protein synthesis increase [8], which is not
only referred to myocardial signal transduction and growth,
but also closely related to MH myocytes and apoptosis [9].
Recent animal studies indicate that ERK activation is a key
factor in regulating cardiac hypertrophy [10]. As we know,
ERK signaling pathways mediate extensive biological eﬀects
[11], involving cell proliferation, cell apoptosis, inﬂamma-
tory responses, oxidative stress, and even inﬂuences of the
form and evolution of tumors. Research has conﬁrmed that
ERK1/2 is closely related to MH and that ERK is activated
through ERK cascade (Ras/Raf/MEK/ERK) [12]. Therefore,
the ERK signaling pathway was chosen as the research
pointcut to explore the inﬂuence of electroacupuncture
(EA) on MH, as well as to provide evidence from basic
experiments to clinical research.
Acupuncture, undeniably the most well-known comple-
mentary and alternative medical treatment, has been proven
as one of the most popular therapies in the world. Multiple
researches conﬁrmed that acupuncture could play a stable
hypotensive eﬀect achieve improvement or normalization of
contractilefunctionand diastolic values, a decreaseof energy
loss, and reversal of MH [13]. It has been well documented
that acupuncture can eﬀectively improve symptoms of
angina, palpitation, and so forth. and improve the left
cardiac function in coronary heart disease patients to inhibit
MH [14], but the signaling pathways mechanism of the
remarkable transformation caused by the treatment remains
unknown.
Neiguan(PC6),aclassicalandexperimentalacupuncture
point, has been recorded in ancient Chinese medical litera-
ture for thousands years and is preferred eﬀectively in treat-
ing cardiovascular disorders. We learned that acupuncture
hadamorepositiveeﬀectinincreasingtheglucosemetabolic
level in a stroke-injured area in the brain than nonacupoint
stimulus and blank controls. In the present study, a real
acupoint Hegu (LI4) located near PC6 was selected as the
control point to compare its therapeutic diﬀerences with
PC6.
Acupuncture indeed improves the cardiac function in
MH, and this eﬀect may have a close relation with ERK
signaling pathway through regulating the role of neuroen-
docrine cytokines. The aim of the current study is to
investigatewhetherEAcouldmediateERKsignalingpathway
through regulating Ang II and ET. Two acupoints, PC6 and
LI4, were also compared to observe the distinctive diﬀerence
between them.
2.MaterialsandMethods
2.1. Animals and Model. Female Sprague-Dawley rats, 3-
month-old, weighing 170–180g, wererandomly divided into
four groups: normal, model, PC6, and LI4 groups, with ten
rats in each group. The rats received free food and water
under a controlled temperature (24 ± 1◦C), with 12 hours
of artiﬁcial light per day.
Following the method by Yin et al. [15], rats were contin-
uously injected every morning with 3mg/kg of isoprinosine
hydrochloride (ISO) into the back skin for 14 days, while
rats in normal group were treated with an equal volume of
physiologic saline, and rats were observed for behavior. The
experimentalprocedureswerecarriedoutinaccordancewith
the guidelines for the care and use of Laboratory Animals
published by National Institutes of Health of the United
States.
2.2. EA. The PC6 rats were given improvised clothing and
subjected to acupuncture on PC6 after an injection of ISO.
TheLI4ratsweretreatedinthesameway,exceptthattheacu-
point was instead of LI4. The acupoints were referred from
the “Map of the Experimental Animal Acupuncture Points,”
formulated by the Experimental Acupuncture Institute of
China Association of Acupuncture and Moxibustion. The
acupuncture needle, 15mm long and 0.3mm in diameter,
was penetrated 2-3mm into the subcutis. The bilateral
acupoints were interconnected with a Hans acupoint nerve
stimulator (HANS) EA apparatus, and the following stimu-
l u sp a r a m e t e r sw e r es e l e c t e d :c o n t i n u o u s - w a v ea t2H za n d
1mA,for20minaday .
2.3. Electrocardiograph (ECG) Recording Electrode Resettle-
ment. A BL-420 physiological function experiment system
(Chengdu TME Technology Co, Ltd, China) was used to
record the standard II-lead ECG. Negative and positive
stainless steel electrodes were placed horizontally beneath
the skin of the left and right forelimbs, and the reference
electrode was placed beneath the skin of the right hind limb.
Recording was performed at a resolution ratio of 500nv/mv
and a chart speed of 50ms/div; 10 cardiac cycles were
included into the calculation.
2.4.UltrastructureObservation. Thecentralventricularmus-
cle of the left ventricular free wall (LVFW) was chopped into
1mm× 1mm× 1mm pieces, ﬁxed in 2.5% glutaraldehyde
for 48h and 1% osmium tetrachloride for 1.5h, dehydrated,
embedded, sectioned, and examined under a Hitachi H-
600transmissionelectronmicroscopy(Japan’sHitachiCom-
pany, Japan).
2.5.MyocardialHypertrophyIndex(MHI). Thebodyweights
of the rats, as well as those of their left ventricle and the
whole heart, were recorded; then their MHI, left ventricular
weight index (LVWI), and the heart weight index (HWI)
were calculated.
2.6. Radioimmunoassay (RIA) Method. The plasma levels of
Ang II and ET were determined with RIA in a full-automatic
Gc-911 RIA counter (Zhong Jia Science and Technology
Industry Company, China). At the end of the experiment,
rats were executed, blood was collected, and plasma was
frozen and stored until assayed. Plasma Ang II and ET
activity was detected with an intrarun coeﬃcient of variation
under 10%; the interrun coeﬃcient of variation under 15%
(Beijing North Institute of Biological Technology, China).
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2.7. Western Blotting. The expression of ERK and phospho-
rylation extracellular signal regulating kinase (p-ERK) in left
ventricle tissue was measured with western blotting. About
100mg left ventricular myocardial tissues was collected
after being departed from heart on ice. The tissues were
homogenized in a tissue lysis buﬀer as turn into lysates.
Then the lysates were centrifuged at 12,000g for 10 minutes,
and the supernatant was transferred into another tube to
be tested. Protein concentrations were determined using
the BCA protein assay (Pierce). Equivalent amounts of
protein (30μg/lane) were resolved electrophoretically by
SDS-polyacrylamide gels (10%) and transferred onto PVDF
membranes. Nonspeciﬁc reactivity was blocked in 5% skim
milk in PBST (10mM Tris-HCl, pH 7.5, 150mM NaCl, 1%
T w e e n - 2 0 )f o r1 ha t6 – 8 ◦C. Afterwards, membranes were
incubated with ERK and P-ERK antibodies (1:200; Santa
Cruz, Calif, USA) overnight at 4◦C, and followed by sec-
ondary antibodies for 1 hour at room temperature. Protein
was visualized by using the enhanced chemiluminescence
system (ECL, Beyotime Institute of Biotechnology, Jiangsu,
China).
2.8. Statistical Analysis. Data were expressed as mean ±
SD and analyzed with one-way ANOVA using SPSS13.0
software. P<0.05 was considered statistically signiﬁcant.
3. Results
3.1. EA Modulated ECG after ISO Injection on Rats. Rats
were observed for behavior, strong heartbeat, and tachypnea
(above the standard 66–114c.p.m., some of them could
reach 150c.p.m.) at 10min after drug injection, and burnout
sleepiness and weakness at 30min after drug injection. ECG-
R-R and ECG-ST were subjected to analysis (Figure 1).
Compared with those in the normal group, the R-R interval
and ST segment were signiﬁcantly higher in the model group
(P<0.05). These two parameters tend to be normal in
the PC6 and LI4 groups compared with the model group
(P<0.05). However, there was no statistically signiﬁcant
diﬀerence between the two EA groups (P>0.05).
3.2. Eﬀect of EA on Cardiac Cell Ultrastructure. MH showed
a series of structural changes, including cardiomyocyte
hypertrophy, interstitial connective tissue hyperplasia, and
coronary circulation capillaries decrease [16]. In the current
study, the rats in the model group mainly manifested
six diﬀerences from the normal group (Figure 2), includ-
ing mitochondria swelling, cell apoptosis, endothelial cell
interstitial hyperplasia, muscle plasma nets expansion, out-
sync contraction of contraction band, and intercalated disc
deformation. With reference to normal group, compared EA
group with model group, EA signiﬁcantly reduced cardiac
muscular tissue injury.
3.3. EA Treatment Downregulated MHI. LVWI and HWI can
reﬂex the MH level, providing an indication of the level of
damage and the restoration of cardiac function. Compared
with the normal group, the LVWIs and HWIs in the model
group were signiﬁcantly higher (P<0.01). Compared with
the model group, the two parameters were lower in the EA
groups (P<0.05). In addition, those in the LI4 group were
superior to those in the PC6 group (P<0.05), as shown in
Figure 3.
3.4. EA Therapy Decreased Two Vasoconstrictors (Ang II and
ET). Figure 4 shows that the Ang II and ET levels in the
model group were signiﬁcantly higher than in the normal
group(P<0.05) whereas these two parameters in EA groups
were lower than those in the model group (P<0.05).
However, there was no statistically signiﬁcant diﬀerence
between these two EA groups (P>0.05), as shown in
Figure 4.
3.5. Eﬀect of EA Downregulated ERK and p-ERK Protein
Expression. The expression of ERK and p-ERK in the model
group were signiﬁcantly higher than that in the normal
group(P<0.05),whereasthesetwoparametersinEAgroups
were lower than in the model group (P<0.05). However,
there was no statistically signiﬁcant diﬀerence between the
t w oE Ag r o u p s( P>0.05), as shown in Figure 5.
4. Discussion
The World Health Organization lists approximately 40 dis-
eases wherein acupuncture treatment is eﬀective [17]. Mod-
ern research has extensively analyzed the beneﬁcial eﬀects
of acupuncture on the cardiovascular system [18]. Growing
evidences showed that acupuncture eﬀect is closely related
to neural mechanism, and it has been well documented
that PC6 can eﬀectively improve symptoms of postoperative
nausea, vomiting [19], labor pain [20], and obese diabetic
[21] via nervous system. To the best of our knowledge, the
current study is the ﬁrst time to report that EA can improve
MH by regulating the ERK signaling pathways through
adjusting upstream neuroendocrine cytokines (Ang II and
ET). The present study is based on neural endocrine system
to discuss the role of EA on MH.
As classical and preferred acupoints in the long history
of China, the “song of eight major points (Ba Zong Xue
Ge)” [22] states that PC6 and LI4 as “for heart and chest,
it is point Neiguan, for face and mouth, Hegu controls,”
which can be combined with clinical practice. Generally, the
use of PC6 in acupuncture is advisable for the treatment of
symptoms of heart and chest diseases, such as palpitation,
stuﬀy chest, angina, nausea, and vomiting. The use of LI4 in
acupuncture is also advisable for the treatment of symptoms
of such diseases as toothache, facial pain, headache, nasal
obstruction, and eye redness. PC6 is often preferred over
LI4 for its improved eﬃcacy in treating cardiovascular
diseases. However, the current study found that LI4 could
have a better eﬀect than PC6, especially with statistically
signiﬁcant diﬀerence in the MHI experiment. These ﬁndings
may be diﬀerent from those of previous researches. In
recent studies, acupuncture induced a signiﬁcant decrease
in the LF/HF ratio and a signiﬁcant increase in HF power;
manual acupuncture at both LI4 and SP6 (Point Sanyinjiao)4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Comparison of the ECG-R-R and ECG-ST in rats for each group (n = 10 each group). ECG images are examples of four groups,
involving 10 cardiac cycles in each ﬁgure. We can ﬁnd out the changes in these pictures, normal group example ((a), R-R interval is 1.31ms
and ST amplitude is 0.06mV), model group example ((b), R-R interval is 1.68ms, and ST amplitude is 0.13mV), PC6 group example ((c),
R-R interval is 1.42ms, and ST amplitude is 0.1mV) and LI4 group example ((d), R-R interval is 1.42ms, and ST amplitude is 0.09mV).
R-R interval prolonged and ST amplitude heightened in (b) while these two values diminished in (c, d).
∗P < 0.05 versus normal;  P < 0.05
versus model;  P > 0.05 versus PC6.
acupoints may play a role in the treatment of dysmenorrhea
with autonomic nervous system involvement [23]. Li et al.
[24] also found that acupuncture on LI4 or PC6 could
regulate heart rate. This may provide exact evidence that
LI4 is useful in regulating the heart rate. In addition, study
of Nayak et al. suggested that electrostimulation application
by point surface electrodes at LI4, ST36 (Zusanli), HT7
(Shenmen), and LR3 (Taichong) points performed sedation
of critically ill patients in the intensive care unit [25]t h u s ,i t
can be suggested that LI4 application in painful diseases is
more extensive than PC6. However, this unexpected result
was only observed once, and further evidence was not
obtained in the current study. Hence, this will be investigated
further in future studies.
In the following respect, this study stimulated the
acupoints with low-current and low-frequency (1mA, 2Hz)
EA. Recent research showed that low-frequency (2Hz) EA
activated many more somatic aﬀerents than high-frequency
stimulationsuchas10and20Hz.Tenminutesofstimulation
by 2Hz EA on healthy volunteers can evaluate in terms
of heart rate variability, pulse rate variability, and skin
conductance response [26]. Similarly, thirty minutes of
low-current, low-frequency (0.3–0.5mA, 2Hz) signiﬁcantly
inhibited the gastric-cardiovascular pressor reﬂex, whereas
a similar period of EA at 40 or 100Hz did not alter
the response [27]. Current topic was designed to discuss
brain stem responses to diﬀerent frequencies at pericardial
acupoints located over the median nerve, and researchersEvidence-Based Complementary and Alternative Medicine 5
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Figure 2:Theultrastructur eofm y ocar diuminratsforeac hgr oup(n = 10eachgroup).Ultrastructurefeaturesinnormalgroup((a) ×4000,
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×5000, (k) ×8000, (l) ×8000). Cardiocyte and micrangium ((a, d, g, j), ×4000∼6000), myoﬁbril, I band, and Z-line ((b, e, h, k), ×8000),
intercalated disc ((c,f,i, l), ×8000∼10000). Some changes of the ultrastructure: mitochondria swelling ((d, e), cell apoptosis (j), endothelial
cell interstitial hyperplasia (d), muscle plasma nets expansion (e), out-sync contraction of contraction band ((e, j), and intercalated disc
deformation ((f, i, l). With reference to normal group, compared EA group with model group, EA signiﬁcantly reduced cardiac muscular
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Figure 3: Eﬀects of EA on LVWI, HWI in rats with MH induced
by ISO (n = 10 each group). MHI: myocardial hypertrophy index,
LVWI: left ventricular weight index, and HWI: heart weight index.
LVWIs and HWIs in the model group were signiﬁcantly higher
compared with the model group. EA lowered the value, and LI4 was
superior to PC6.
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Figure 4: Eﬀects of EA on the ratios of circulating Ang II, ET in rats
for each group (n = 10 each group). The plasma Ang II, ET level
of model group was signiﬁcantly increased compared with normal
group. EA decreased these cytokines, but there was no statistically
signiﬁcant diﬀerence between PC6 group and LI4 group.
∗P < 0.05
versus normal;  P < 0.05 versus model;  P > 0.05 versus PC6.
discovered that premotor sympathetic cardiovascular neu-
rons that receive convergent input from the splanchnic
and median nerves during low-frequency EA and manual
acupuncture were inhibited similarly for prolonged periods
by low-frequency [28].
ECG is often regarded as the basic indicator for judging
cardiacfunction.AnincreaseintheQRSinterval[29,30]and
a changing ST-T interval [31] provide an accurate diagnosis
of MH. Considerable evidence documents that changes of
the ST-segment is an eﬀective indicator of the severity of
myocardial ischemia [32]. The current study found that
the R-R intervals were elongated and ST-T amplitudes were
evidently increased in the model group and that EA could
regulate the values. This indicates that EA on PC6 or LI4 can
be medicative for MH.
Our experimental results showed that Ang II and ET
participate in the formation of MH and that EA can improve
MH by regulating the role of neuroendocrine-cytokines. The
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Figure 5: Eﬀects of EA on the expression of ERK1/2 and p-ERK
in cardiac muscular tissue in rats for each group (n = 10 each
group). Western blotting was performed on protein extracts from
left ventricular myocardial tissue. Quantitative analysis revealed a
signiﬁcant increase in model group while decrease in EA groups.
However, there was no statistical signiﬁcance diﬀerence between
PC6 group and LI4 group.
∗P < 0.05 versus normal;  P < 0.05
versus model;  P > 0.05 versus PC6.
development of MH induced by hemodynamic overload
is very likely initiated by mechanical stress. However, the
involvement of growth promoting factors (e.g., TGF-b and
VEGF), hormones (such as Ang II and ET-1), and cytokines
(for instance CT-1) cannot be foreclosed [33]. As a main
active metabolite of renin-angiotensin system, Ang II plays
a key role in promoting MH and myocardial ﬁbrosis [34].
Previous literature has shown that endogenous Ang II can
enhance MH due to ISO in rats [35]. Ang II in cardiac inter-
stitial tissue is produced in the transformation of chymase
and has a cardioactive eﬀect on myocardial and sympathetic
nerve endings that regulate cardiac pressure chronotropic
action and promote MH [36]. As the strongest vasocon-
strictor yet discovered, ET participates in the pathogenesis
of various cardiac diseases, such as myocardial ischemia and
hypertension [37].
The mitogen-activated protein kinases (MAPKs) sig-
nal pathway, including extracellular signal-regulated kinaseEvidence-Based Complementary and Alternative Medicine 7
Figure 6: EA improves ERK signaling pathways through the
regulation of neuroendocrine cytokines in myocardial hypertrophic
rats. The proposed hypothetic mechanism of acupuncture aﬀecting
theheartacupunctureindeedimprovesthecardiacfunctioninMH,
and this eﬀect has a close relation with ERK signaling pathway
through regulating the role of neuroendocrine cytokines.
(ERK)1/2, c-Jun NH2-terminal kinase (JNK), and p38
kinase, has been recognized as a central mechanism under-
lying development of many types of cardiovascular disease,
including cardiac failure and hypertrophy [38]. As the latest
and the most important pathway, ERK is mainly activated
by the Ras/Raf/MEK/ERK cascade. This pathway involves a
module of four protein kinases, ERK, MEK, Raf, and Ras. As
a low-molecular-weight GTPase, the small (21-kDa) guanine
nucleotide-binding protein Ras plays a central role in the
regulation of cell growth and division and it acts as upstream
molecule to regulate raf [39]. There are three isozyme in
Raf family, Raf-1, A-Raf, and B-Raf [40]. Raf-1 has been
reported to be activated by Ras.GTP acts as a key protein
kinase to activate dual protein kinase MEK [41]. MEK
in turn activates ERKs by phosphorylating their threonine
and tyrosine residues [42]. ERK exists in two isoforms in
mammalian cells, ERK1 and ERK2. P-ERK is a homocysteine
thiolactone that is eventually transported into nuclear and
acts on downstream transcription factors (ELK, AP-1, NF-
κB, and etc.) and then regulates related protooncogenes
(such as c-fos, c-myc, c-jun, jun-B, and Egr-1), which lead
to MH. ERK is not only an important regulating factor in the
nervous system and in cell division, but also essential for the
signaling pathways of various cytokines (ET-1, NA, Ang II,
etc.)thatpromoteMH[43].TheERKsignalingpathwayscan
be stimulated upon G protein coupled receptor occupation
by binding of hormones (by binding of ET-1 [44]a n dA n g
II [45]). The current study found that EA could inhibit the
expression of ERK and p-ERK protein through mediating
various cytokines to improve cardiac function in MH.
5. Conclusion
In summary, acupuncture improves cardiac function in MH,
and this eﬀect is closely related with the ERK signaling path-
ways through the regulation of neuroendocrine cytokines
(Figure 6). EA stimulation of LI4 may be more eﬀective than
stimulation of PC6 in MH rats. This contrasts with previous
research and could be a singular phenomenon that needs
further veriﬁcation.
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